15:59 May 29

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
736.10
-18.10 (-2.40%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alembic Pharmaceuticals Ltd. Financials

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
736.10
-18.10 (-2.40%)
15:59 May 29
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

45/100
Mid Valuation

Technical

40/100
Technically Neutral

Strength

7

Weakness

3

Opportunity

1

Threats

1

11.89 %

ROE %

7.70 %

ROA %

34.33

EPS

288.72

BVPS

9.18 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
5305.79 5652.62 6228.62 6672.08 7344.9
Operating Expenses +
4431.63 4944.24 5295.27 5663.84 6226.43
Raw Material
1489.61 1630.17 1857.92 2083.13 2256.26
Increase Decrease in Cost
-43.19 78.65 -142.84 -289.77 -271.81
Other Manufacturing Expense
0 50.9 0 0 0
Employee Cost
1133 1169.13 1446.29 1562.34 1731.93
Miscellaneous Expenses
2573.21 2775.57 3043.72 3130.06 3527.81
Operating Profit
874.16 708.38 933.35 1008.24 1118.47
Other Income
50.46 2.74 28.31 42.55 54.41
Depreciation
286.78 275.43 272.67 278.58 318.55
Interest
17.73 50.17 56.19 78.77 93.63
Profit before tax and exceptio..
620.11 385.52 632.8 693.44 760.7
Exceptional Items
0 0 0 12.87 -66.99
PBT
620.11 385.52 632.8 706.31 693.71
Provision for Taxation
104.46 12.61 16 125.17 23.12
Net Profit
515.65 372.91 616.8 581.14 670.59
NET Profit after MI
520.94 341.99 615.82 583.42 674.77
EPS
26.5 17.4 31.33 29.68 34.33
Operating Profit Margin (%)
16.48 12.53 14.98 15.11 15.23
Net Profit Margin (%)
9.82 6.05 9.89 8.74 9.19

Alembic Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 69.70 69.70 69.70 69.70 69.70 69.60
FII 4.30 4.20 4.00 4.00 3.90 4.20
Public 16.10 16.20 16.30 16.40 16.50 16.00
Others 9.90 9.90 10.00 9.90 9.90 10.20
Shareholder Shares Holding %
Download Our App On: